Atlas Trials

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa

Clinical trial NCT00866476 · TERMINATED

Trial details

NCT number
NCT00866476
Sponsor
University of Maryland, Baltimore
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Shigella
Start date
2010-01-01
Primary completion
2010-02-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.